FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine. First invention represents a liquid composition in the form of emulsion or microemulsion for rectal administration for use in diagnostic endoscopic assessment of sigmoid colon and/or rectum, composed in the form of an enema and/or cleaning solution and containing at least one dye, at least one emulsifier, at least one physiologically acceptable excipient and at least one polymer with reverse thermal sensitivity. Second invention represents a method of endoscopic procedure for detecting pathological and/or non-pathological forms of sigmoid and/or rectal mucosa in a subject, involving administering said composition.
EFFECT: group of inventions provides simpler and safer introduction of the dye while ensuring high efficiency of staining and therefore more effective identification of pathological and/or non-pathological regions.
26 cl, 8 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
EMULSION OR MICROEMULSION FOR USE IN ENDOSCOPIC RESECTION OF MUCOSA AND/OR ENDOSCOPIC SUBMUCOUS DISINTEGRATION | 2014 |
|
RU2696263C1 |
EMULSIONS OR MICROEMULSIONS FOR USE IN ENDOSCOPIC MUCOSAL RESECTIONING AND/OR ENDOSCOPIC SUBMUCOSAL DISSECTION | 2014 |
|
RU2676278C1 |
SOLID COMPOSITION FOR ORAL ADMINISTRATION OF DYES AND DIAGNOSTIC APPLICATION THEREOF | 2011 |
|
RU2561034C2 |
SOLID ORAL COMPOSITION CONTAINING COLORS FOR APPLICATION IN ENDOSCOPIC DIAGNOSTICS | 2013 |
|
RU2649783C2 |
SOLID COMPOSITION FOR DELIVERY | 2018 |
|
RU2812928C2 |
ORAL RIFAMYCIN SV COMPOSITIONS | 2018 |
|
RU2793319C2 |
METHOD OF PANCHROMOENDOSCOPY OF LARGE INTESTINE MUCOSA | 2010 |
|
RU2427311C1 |
HIGHLY CONCENTRATED COMPOSITION | 2016 |
|
RU2731564C2 |
COMPOSITION BASED ON NANOPARTICLES WITH IMPROVED PENETRATION THROUGH MUCOUS MEMBRANES | 2013 |
|
RU2598627C2 |
SOLID COMPOSITIONS CONTAINING 5-AMINOLEVULINIC ACID | 2010 |
|
RU2527328C2 |
Authors
Dates
2020-01-24—Published
2015-01-29—Filed